Progyny (NASDAQ:PGNY – Get Free Report) had its price target lowered by stock analysts at BTIG Research from $35.00 to $30.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s target price suggests a potential upside of 70.26% from the stock’s current price. PGNY has […]

Theravance Biopharma (NASDAQ:TBPH – Free Report) had its price objective lowered by BTIG Research from $40.00 to $21.00 in a research note issued to investors on Tuesday morning, Marketbeat.com reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. TBPH has been the topic of a number of other reports. HC Wainwright […]

Okta (NASDAQ:OKTA – Free Report) had its target price decreased by BTIG Research from $116.00 to $90.00 in a research note issued to investors on Monday morning,Benzinga reports. BTIG Research currently has a buy rating on the stock. Several other research analysts also recently issued reports on the stock. Sanford C. Bernstein restated an “outperform” […]

CrowdStrike (NASDAQ:CRWD – Get Free Report) had its price target dropped by investment analysts at BTIG Research from $640.00 to $499.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price objective would indicate a potential upside of 34.15% from the stock’s current […]

DraftKings (NASDAQ:DKNG – Free Report) had its price target lowered by BTIG Research from $37.00 to $35.00 in a report issued on Thursday,Benzinga reports. BTIG Research currently has a buy rating on the stock. A number of other analysts also recently issued reports on DKNG. JPMorgan Chase & Co. decreased their price objective on shares […]

MercadoLibre (NASDAQ:MELI – Free Report) had its target price cut by BTIG Research from $2,750.00 to $2,650.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the stock. MELI has been the topic of a number of other reports. Zacks Research upgraded MercadoLibre from a “strong sell” rating to a […]

GeneDx (NASDAQ:WGS – Free Report) had its price objective reduced by BTIG Research from $200.00 to $170.00 in a research note published on Tuesday, MarketBeat reports. BTIG Research currently has a buy rating on the stock. A number of other research analysts have also recently commented on WGS. Weiss Ratings reissued a “sell (d)” rating […]

Enovix (NASDAQ:ENVX – Get Free Report) had its price objective reduced by investment analysts at Craig Hallum from $16.00 to $10.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price target indicates a potential upside of 67.08% from the company’s current price. Other research […]

Workday (NASDAQ:WDAY – Get Free Report) had its target price dropped by Mizuho from $275.00 to $210.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the software maker’s stock. Mizuho’s target price indicates a potential upside of 58.21% from the company’s previous close. Other analysts have also […]

Workday (NASDAQ:WDAY – Get Free Report) had its price objective cut by investment analysts at BTIG Research from $230.00 to $175.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the software maker’s stock. BTIG Research’s price objective indicates a potential upside of 34.38% from the […]

MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) had its price target increased by BTIG Research from $24.00 to $30.00 in a research report released on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other research analysts also recently issued reports on the stock. Zacks Research downgraded shares of MoonLake Immunotherapeutics […]